Marika Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Marika Inc
TickerPVLA
CIK #0001583648
CUSIP697947109
SectorTrade & Services - Services-Business Services, Nec
Address2360 Corporate Circle Suite 400, Henderson, NV 89074
Source [EDGAR]
CIK Filing 2011 - 2025
[0001583648] 10-K
[0001583648] 10-Q
[0001583648] 3
[0001583648] 4
[0001583648] 8-K
[0001583648] D
[0001583648] SC 13D
[0001583648] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Frazier Life Sciences Public Fund LP Palvella Therapeutics Inc [2025-01-08] 0.0
Kaupinen WES Palvella Therapeutics Inc [2024-12-20] 0.0
Suvretta Capital Management LLC Palvella Therapeutics Inc [2024-12-20] 0.0
Samsara Biocapital LP Palvella Therapeutics Inc [2024-12-20] 0.0
Dellora Investments LP Pieris Pharmaceuticals Inc [2024-08-07] 0.0
Adar1 Capital Management LLC Pieris Pharmaceuticals Inc [2024-08-01] 10.5
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2024-05-17] 10.4
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2024-05-17] 10.4
Checkpoint Capital LP Pieris Pharmaceuticals Inc [2023-06-12] 6.0
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2023-05-22] 11.8
Soleus Capital Master Fund LP Pieris Pharmaceuticals Inc [2023-01-27] 5.4
Lynx1 Capital Management LP Pieris Pharmaceuticals Inc [2022-10-24] 5.1
Soleus Capital Master Fund LP Pieris Pharmaceuticals Inc [2022-01-27] 5.4
Citadel Advisors LLC Pieris Pharmaceuticals Inc [2021-07-06] 4.9
Astrazeneca PLC Pieris Pharmaceuticals Inc [2021-04-08] 5.66
Seagen Inc Pieris Pharmaceuticals Inc [2021-04-02] 6.2
Nussbaum Ran Pieris Pharmaceuticals Inc [2021-02-16] 6.4
BlackRock Inc Pieris Pharmaceuticals Inc [2020-02-07] 6.2
EcoR1 Capital LLC Pieris Pharmaceuticals Inc [2019-11-14] 8.8
Aquilo Capital Management LLC Pieris Pharmaceuticals Inc [2019-10-07] 5.1
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2016-06-17] 4.1
Lombard Odier Asset Management USA Corp Pieris Pharmaceuticals Inc [2016-02-16] 7.17
Tekla Capital Management LLC Pieris Pharmaceuticals Inc [2016-02-12] 0.7
Novo Nordisk A S Pieris Pharmaceuticals Inc [2016-01-28] 5.2
Global Life Bioventure IV SARL Pieris Pharmaceuticals Inc [2015-09-11] 6.25
Tompkins Mark N Pieris Pharmaceuticals Inc [2015-07-10] 5.6
OrbiMed Advisors LLC Pieris Pharmaceuticals Inc [2015-07-09] 18.8
Form 3/4/5 Filer 2011 - 2025
Wessel Tadd S.
Palvella Therapeutics Inc
Davis Todd C
Heron Elaine J
Jenkins George M
Kiritsy Christopher P
Kline Ashley Hartmann
Martini Jeffrey S
Goin Kathleen
Korenberg Matthew E
BVF II GP LLC
BVF Partners OS Ltd.
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
Lampert Mark N
BVF I GP LLC
BVF Partners L P/IL
Biotechnology Value Trading Fund OS LP
BVF Inc/IL
BVF GP Holdings LLC
Kaupinen Wes
Dellora Investments LP
Geraghty James A
ADAR1 Capital Management, LLC
ADAR1 Partners, LP
Richman Michael
Said Maya R.
Barbier Ann
Sherman Matthew L
Kiener Peter A
Yoder Stephen S.
Olwill Shane
Mousa Ahmed
Kaufmann Hitto
Bures Thomas
Demuth Tim
Aquilo Capital Management, LLC
Bizzari Jean-Pierre
Reine Allan
Matis Louis
Prelack Steven
OrbiMed Capital GP III LLC
OrbiMed Advisors LLC
Adams Julian
Isaly Samuel D
Khuong Chau Quang
Thibault Lance E
Knopf Claude
Deptula-Hicks Darlene M
Takke Christina
Form 13F Holdings
Firm Period DFND Voting Shares
Frazier Life Sciences Management LP [2025-06-30] SOLE 722,400 722,400
Suvretta Capital Management LLC [2025-06-30] SOLE 714,463 714,463
BVF Inc/IL [2025-06-30] DFND 0 696,555
Woodline Partners LP [2025-06-30] SOLE 445,615 445,615
BlackRock, Inc. [2025-06-30] SOLE 438,791 445,052
Samsara Biocapital LLC [2025-06-30] SOLE 339,743 339,743
Millennium Management LLC [2025-06-30] SOLE 314,989 314,989
Adams Street Partners LLC [2025-06-30] SOLE 298,986 298,986
Nantahala Capital Management LLC [2025-06-30] SOLE 250,062 250,062
Geode Capital Management LLC [2025-06-30] DFND 173,986 173,986
Vanguard Group Inc [2025-06-30] SOLE 0 153,476
Morgan Stanley [2025-06-30] DFND 28,950 135,754
Blue Owl Capital Holdings LP [2025-06-30] DFND 0 125,259
Sectoral Asset Management Inc [2025-06-30] SOLE 0 95,615
CLIO Asset Management LLC [2025-06-30] SOLE 0 91,508
Goldman Sachs Group Inc [2025-06-30] DFND 85,329 85,329
State Street Corp [2025-06-30] DFND 75,027 82,011
Royce & Associates LP [2025-06-30] SOLE 74,516 74,516
AWM Investment Company Inc [2025-06-30] SOLE 69,416 69,416
Renaissance Technologies LLC [2025-06-30] SOLE 66,858 66,858
J Goldman & Co LP [2025-06-30] SOLE 56,290 56,290
Northern Trust Corp [2025-06-30] DFND 53,453 53,453
Marshall Wace LLP [2025-06-30] OTR 0 49,077
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM [2025-06-30] DFND 43,994 43,994
DAFNA Capital Management LLC [2025-06-30] SOLE 43,348 43,348
UBS Group AG [2025-06-30] DFND 43,149 43,149
Susquehanna International Group LLP [2025-06-30] OTR 17,384 27,284
Charles Schwab Investment Management Inc [2025-06-30] SOLE 21,013 21,013
Cresset Asset Management LLC [2025-06-30] SOLE 20,911 20,911
Strid Group LLC [2025-06-30] SOLE 0 18,166
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com